Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Immuneering Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +3 vs. Q3 2022
- Shares held
- 11.7M
- −282.1K (−2.3%) vs. Q3 2022
- Total value
- $56.9M
- −$114.8M (−66.9%) vs. Q3 2022
- New holders
- 7
- 10 more added
- Sold out
- 4
- 11 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 76 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 81 | $0 | 0.00% | +81 | New |
| Credit Suisse AG | 58 | $281 | 0.00% | +58 | New |
| Wells Fargo & Company | 124 | $601 | 0.00% | −997−88.9% | Reduced |
| China Universal Asset Management Co., Ltd. | 268 | $1.30K | 0.00% | +21+8.5% | Added |
| Citigroup Inc | 403 | $1.96K | 0.00% | −3,806−90.4% | Reduced |
| Bank of America Corp | 531 | $2.58K | 0.00% | +493+1,297.4% | Added |
| JPMorgan Chase & Co | 960 | $5.00K | 0.00% | −183−16.0% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,148 | $20.1K | 0.00% | +4,148 | New |
| Tower Research Capital LLC (TRC) | 6,376 | $31.0K | 0.00% | +3,659+134.7% | Added |
| Barclays PLC | 6,758 | $32.8K | 0.00% | +2,168+47.2% | Added |
| Goldman Sachs Group Inc | 10,277 | $49.8K | 0.00% | −1,551−13.1% | Reduced |
| Man Group plc | 18,368 | $89.1K | 0.00% | +18,368 | New |
| Qube Research & Technologies Ltd | 19,394 | $94.1K | 0.00% | +6,079+45.7% | Added |
| Millennium Management LLC | 19,670 | $95.0K | 0.00% | +9,406+91.6% | Added |
| Gsa Capital Partners LLP | 23,371 | $113.0K | 0.01% | −9,739−29.4% | Reduced |
| Anson Funds Management LP | 32,603 | $158.1K | 0.05% | +32,603 | New |
| Northern Trust Corp | 34,660 | $168.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 34,949 | $169.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 45,000 | $218.3K | 0.00% | +45,000 | New |
| Morgan Stanley | 45,416 | $220.3K | 0.00% | +33,667+286.6% | Added |
| CI Private Wealth, LLC | 47,419 | $230.0K | 0.00% | +47,419 | New |
| State Street Corp | 54,035 | $262.1K | 0.00% | +24,900+85.5% | Added |
| Adage Capital Partners GP, L.L.C. | 75,000 | $363.8K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 82,547 | $409.4K | 0.00% | +110.0% | Added |
| TD Asset Management Inc | 146,714 | $711.6K | 0.00% | −947−0.6% | Reduced |
| FMR LLC | 153,063 | $742.4K | 0.00% | −69,951−31.4% | Reduced |
| Geode Capital Management, LLC | 169,219 | $820.0K | 0.00% | −372−0.2% | Reduced |
| T. Rowe Price Investment Management, Inc. | 458,233 | $2.22M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 837,679 | $4.06M | 0.00% | +19,190+2.3% | Added |
| BlackRock Inc. | 1,348,384 | $6.54M | 0.00% | −75,650−5.3% | Reduced |
| Citadel Advisors LLC | 2,141,497 | $10.4M | 0.01% | −43,412−2.0% | Reduced |
| Cormorant Asset Management, LP | 2,286,181 | $11.1M | 0.75% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,619,560 | $17.6M | 0.00% | −43,932−1.2% | Reduced |
| Buckingham Strategic Wealth, LLC | 0 | $0 | 0.00% | −200,200−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −67,160−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −11,366−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Kore Private Wealth LLC | – | – | – | – | Not filed |